nach oben

Psychiatric Quarterly

Erschienen in:

31.03.2020 | Original Paper

Using the CHIME Personal Recovery Framework to Evaluate the Validity of the MHRM-10 in Individuals with Psychosis

verfasst von: Madeline Lim, Huiting Xie, Ziqiang Li, Bhing Leet Tan, Jimmy Lee

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

The recovery movement has revealed that outcomes which focuses on just symptoms and functioning may not be holistic and that consumer-rated outcomes may contribute to a more holistic and person-centric care model. However, a brief and effective measure is required in clinical settings; hence, the aim of the current study is to evaluate the psychometric properties of the briefest personal recovery measure- Mental Health Recovery Measure-10 items, using the CHIME (Connectedness, Hope and optimism about the future, Identity, Meaning in life, Empowerment) personal recovery framework. 64 outpatients with schizophrenia or schizoaffective disorder were assessed at two time points, 2 weeks apart. Data collected included sociodemographic information, MHRM-10, Psychological factors related to the CHIME framework, in respective order: RYFF subscale positive relations with others; Herth Hope Index (HHI); Internalized Stigma of Mental Illness (ISMI) and RYFF subscale self-acceptance; World Health Organization Quality of Life- BRIEF (WHOQOL-BREF); Empowerment, and Clinical factors- symptoms as measured by Positive and Negative Syndrome Scale, functioning (PSP) and depressive symptoms (CDSS). MHRM-10 demonstrated convergent validity with CHIME personal recovery psychological factors (all ρ > 0.5). MHRM-10 had excellent internal consistency (Cronbach’s alpha = 0.904) and adequate test-retest reliability (ρ = 0.742, p < 0.001). Initial factor structure analysis revealed a one factor structure. The MHRM-10 is a valid instrument for use and can serve as a tool to facilitate a more collaborative and person-centric model of care for individuals with psychosis.

Remington G, Foussias G, Agid O. Progress in defining optimal treatment outcome in schizophrenia. CNS Drugs. 2010;24(1):9–20. https://doi.org/10.2165/11530250-000000000-00000.CrossRefPubMed

Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiol Psichiatr Soc. 2008;17(2):128–37.CrossRef

Lim MW, Remington G, Lee J. Personal recovery in serious mental illness: making sense of the concept. Ann Acad Med Singap. 2017;46(1):29–31.PubMed

Karow A, Naber D, Lambert M, Moritz S. Remission as perceived by people with schizophrenia, family members and psychiatrists. Eur Psychiatry. 2012;27(6):426–31. https://doi.org/10.1016/j.eurpsy.2011.01.013.CrossRefPubMed

Fervaha G, Takeuchi H, Agid O, Lee J, Foussias G, Remington G. Determinants of patient-rated and clinician-rated illness severity in schizophrenia. J Clin Psychiatry. 2015;76(7):924–30. https://doi.org/10.4088/JCP.14m09128.CrossRefPubMed

Fervaha G, Agid O, Takeuchi H, Foussias G, Remington G. Life satisfaction and happiness among young adults with schizophrenia. Psychiatry Res. 2016;242:174–9. https://doi.org/10.1016/j.psychres.2016.05.046.CrossRefPubMed

Fervaha G, Agid O, Takeuchi H, Foussias G, Lee J, Remington G. Clinical and functional outcomes in people with schizophrenia with a high sense of well-being. J Nerv Ment Dis. 2015;203(3):187–93. https://doi.org/10.1097/NMD.0000000000000266.CrossRefPubMed

Chan RCH, Mak WWS, Chio FHN, Tong ACY. Flourishing with psychosis: a prospective examination on the interactions between clinical, functional, and personal recovery processes on well-being among individuals with schizophrenia spectrum disorders. Schizophr Bull. 2018;44(4):778–86. https://doi.org/10.1093/schbul/sbx120.CrossRefPubMed

Armstrong NP, Cohen AN, Hellemann G, Reist C, Young AS. Validating a brief version of the mental health recovery measure for individuals with schizophrenia. Psychiatr Serv. 2014;65(9):1154–9. https://doi.org/10.1176/appi.ps.201300215.CrossRefPubMed

10.

Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry. 2011;199(6):445–52. https://doi.org/10.1192/bjp.bp.110.083733.CrossRefPubMed

11.

Shanks V, Williams J, Leamy M, Bird VJ, Le Boutillier C, Slade M. Measures of personal recovery: a systematic review. Psychiatr Serv. 2013;64(10):974–80. https://doi.org/10.1176/appi.ps.005012012.CrossRefPubMed

12.

Abraham KM, Nelson CB, Ganoczy D, Zivin K, Brandfon S, Walters H, et al. Psychometric analysis of the mental health recovery measure in a sample of veterans with depression. Psychol Serv. 2016;13(2):193–201. https://doi.org/10.1037/ser0000067.CrossRefPubMed

13.

Bullock W. A, Young, S. L. . The Mental Health Recovery Measure (MHRM). 111th Annual Meeting of the Toronto, ON: American Psychological Association 2003.

14.

Young SL, Ensing DS. Exploring recovery from the perspective of people with psychiatric disabilities. Psychiatr Rehabil J. 1999;22(3):219–31. https://doi.org/10.1037/h0095240.CrossRef

15.

Theodora Campbell-Orde JC, Jenneth Carpenter H. Stephen Leff. Measuring the Promise: A compendium of Recovery Measures Human Services Research Institute vol II. 2005.

16.

Bullock W. A. The mental health recovery measure (MHRM): updated normative data and psychometric properties. Toledo, Ohio: University of Toledo 2009.

17.

Jiang J, Sim K, Lee J. Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population. Schizophr Res. 2013;143(1):38–43. https://doi.org/10.1016/j.schres.2012.10.019.CrossRefPubMed

18.

Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3(4):247–51. https://doi.org/10.1016/0920-9964(90)90005-R.CrossRefPubMed

19.

Lako IM, Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, et al. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. J Affect Disord. 2012;140(1):38–47. https://doi.org/10.1016/j.jad.2011.10.014.CrossRefPubMed

20.

Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, et al. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale. Psychopathology. 2012;45(5):276–85. https://doi.org/10.1159/000336729.CrossRefPubMed

21.

Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the personal and social performance scale in patients with stable schizophrenia. Psychiatry Res. 2008;161:213–24. https://doi.org/10.1016/j.psychres.2007.11.012.CrossRefPubMed

22.

Kawata AK, Revicki DA. Psychometric properties of the personal and social performance scale (PSP) among individuals with schizophrenia living in the community. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care & Rehabilitation. 2008;17(10):1247–56. https://doi.org/10.1007/s11136-008-9400-z.CrossRef

23.

Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992;17(10):1251–9. https://doi.org/10.1111/j.1365-2648.1992.tb01843.x.CrossRefPubMed

24.

Boyd JE, Otilingam PG, DeForge BR. Brief version of the internalized stigma of mental illness (ISMI) scale: psychometric properties and relationship to depression, self esteem, recovery orientation, empowerment, and perceived devaluation and discrimination. Psychiatr Rehabil J. 2014;37(1):17–23. https://doi.org/10.1037/prj0000035.CrossRefPubMed

25.

Rogers ES, Chamberlin J, Ellison ML, Crean T. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48(8):1042–7. https://doi.org/10.1176/ps.48.8.1042.CrossRefPubMed

26.

Wowra SA, McCarter R. Validation of the empowerment scale with an outpatient mental health population. Psychiatr Serv. 1999;50(7):959–61. https://doi.org/10.1176/ps.50.7.959.CrossRefPubMed

27.

Organization WH. WHOQOL-BREF introduction. Scoring and Generic Version of the Assessment: Administration; 1996.

28.

Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2004;13(2):299–310.

29.

Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, N.J.: L. Erlbaum Associates; 1988.

30.

Costello A. B, Osborne J. W. Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. In: Boyle G. J, O'Gorman J. G, Fogarty G. J, . Work and organisational psychology: Research methodology; Assessment and selection; Organisational change and development; Human resource and performance management; Emerging trends: Innovation/globalisation/technology., Vols. 1–5. Sage benchmarks in psychology. Thousand Oaks, CA: Sage Publications, Inc; 2016. p. 125–36.

31.

Bird V, Leamy M, Tew J, Le Boutillier C, Williams J, Slade M. Fit for purpose? Validation of a conceptual framework for personal recovery with current mental health consumers. Aust N Z J Psychiatry. 2014;48(7):644–53. https://doi.org/10.1177/0004867413520046.CrossRefPubMed

32.

Ye S, Pan JY, Wong DFK, Bola JR. Cross-validation of mental health recovery measures in a Hong Kong Chinese sample. Res Soc Work Pract. 2013;23(3):311–25. https://doi.org/10.1177/1049731512471861.CrossRef

Titel: Using the CHIME Personal Recovery Framework to Evaluate the Validity of the MHRM-10 in Individuals with Psychosis
verfasst von: Madeline Lim
Huiting Xie
Ziqiang Li
Bhing Leet Tan
Jimmy Lee
Publikationsdatum: 31.03.2020
Verlag: Springer US
Erschienen in: Psychiatric Quarterly / Ausgabe 3/2020
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI: https://doi.org/10.1007/s11126-020-09737-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Impact of Collateral on Emergency Department Length of Stay in College-Aged Patients

Psychopathological Comorbid Symptoms in Animal Hoarding Disorder

Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder

The Effect of COVID-19 on Youth Mental Health